The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an ...

As obesity drug heavyweights Eli Lilly and Novo Nordisk gear up to release results for the third quarter, investors are ...

After a “horrible experience with Wegovy,” the comedian revealed in March that taking Mounjaro was working “really great” for her.

Somehow, it’s becoming even harder to get a GLP-1.

Amy Schumer's recent appearance in a red Valentino dress highlighted her comfort in her own skin after significant weight ...

Eli Lilly said on Wednesday it is partnering with Walmart to sell its weight-loss treatment Zepbound at the retailer's ...

BMI is a measure of body weight relative to height. The goal for most people is to have a BMI that’s over 18 and under 25.

The 44-year-old comedian — who has shed 'at least 40lbs' with help from GLP-1 weight loss drug Mounjaro — showed off her ...

A few things happen when you get a corticosteroid injection at the dermatologist’s office. “We inject it into active inflamed ...

Despite all that, there are some good reasons to consider buying into Novo Nordisk -- and the best is its low valuation, given its growth potential. The stock's recent price-to-earnings (P/E) ratio of ...

Health care costs have been rising quickly for years in Vermont. But the end of certain subsidies means people will pay more for less coverage.